Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Carcinogenesis
|
355 | 0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv | 0.050 | 1.000 | 5 | 2008 | 2016 | ||||||
Carcinoma
|
103 | 0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Carcinoma in situ of uterine cervix
|
18 | 0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Carcinoma of bladder
|
309 | 0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv | 0.070 | 1.000 | 7 | 2010 | 2015 | ||||||
Carcinoma of larynx
|
65 | 0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Carcinoma of lung
|
1204 | 0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv | 0.100 | 0.875 | 16 | 2000 | 2018 | ||||||
Carcinoma, Basal Cell
|
91 | 0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv | 0.020 | 1.000 | 2 | 2006 | 2009 | ||||||
Carcinoma, Ovarian Epithelial
|
327 | 0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv | 0.020 | 1.000 | 2 | 2012 | 2015 | ||||||
Central neuroblastoma
|
231 | 0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Cerebrovascular accident
|
591 | 0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv | 0.030 | 1.000 | 3 | 2011 | 2019 | ||||||
cervical cancer
|
268 | 0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv | 0.100 | 0.900 | 10 | 2002 | 2016 | ||||||
Cervical Intraepithelial Neoplasia
|
29 | 0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv | 0.020 | 1.000 | 2 | 2014 | 2014 | ||||||
Cervical Squamous Cell Carcinoma
|
44 | 0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv | 0.010 | 1.000 | 1 | 2000 | 2000 | ||||||
Cervix carcinoma
|
283 | 0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv | 0.100 | 0.909 | 11 | 2002 | 2016 | ||||||
Childhood Acute Lymphoblastic Leukemia
|
261 | 0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Childhood Acute Megakaryoblastic Leukemia
|
4 | 0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv | 0.010 | 1.000 | 1 | 2000 | 2000 | ||||||
Childhood Glioblastoma
|
98 | 0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Childhood Hodgkin Lymphoma
|
29 | 0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv | 0.010 | 1 | 2011 | 2011 | |||||||
Childhood Kidney Wilms Tumor
|
36 | 0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Childhood Leukemia
|
140 | 0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv | 0.020 | 2 | 2012 | 2016 | |||||||
Childhood Lymphoma
|
66 | 0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Childhood Medulloblastoma
|
25 | 0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv | 0.020 | 1.000 | 2 | 2003 | 2012 | ||||||
Childhood Myelodysplastic Syndrome
|
20 | 0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Childhood Neuroblastoma
|
231 | 0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Childhood Non-Hodgkin Lymphoma
|
39 | 0.439 | 0.800 | 17 | 7676153 | missense variant | GG/AC | mnv | 0.010 | 1.000 | 1 | 2004 | 2004 |